Announcing its findings in May 2024, the inquiry said victims had been failed "not once, but repeatedly", and that the risk of viral infections in blood products had been known since 1948.
FDA Breakthrough Device Designation for its UllCORE Bloodstream Infection Test Barcelona, Spain – 2 December 2024 – deepull, a medical diagnostics company developing culture-free diagnostic solutions ...